Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome

Summary

This is an exploratory clinical investigation. The objectives of this study are to evaluate the safety, steady-state pharmacokinetics, and efficacy of metyrosine (Demser®) for the treatment of psychosis in patients with velocardiofacial syndrome (VCFS).

Timeline

Start

2010-06

Primary completion

2010-11

Completion

2011-09

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment, study-design and execution challenges.”

Drugs

Indications